Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Pediatric Infectious Disease Journal|May 27, 2021
Taking a Rational Approach to a Reported Antibiotic AllergyDagmar Berghuis, Merel M C Lambregts, Mark G J de Boer
Cancer Immunology, Immunotherapy : CII|July 3, 2016
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapyLaurens G L Sand, Dagmar Berghuis, Karoly Szuhai, et al.
Frontiers in Immunology|April 30, 2019
B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Dagmar Berghuis, Mirjam van der Burg, et al.
Journal of Human Immunity|May 22, 2026
Clinical challenges following early detection of ataxia telangiectasia through SCID newborn screeningThomas J Weitering, Dagmar Berghuis, Maartje Blom, et al.
The Journal of Pathology|December 21, 2010
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progressionDagmar Berghuis, Susy J Santos, Hans J Baelde, et al.
Clinical Sarcoma Research|May 17, 2012
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysisDagmar Berghuis, Marco W Schilham, Hanneke I Vos, et al.
Frontiers in Immunology|May 24, 2021
Modeling Influencing Factors in B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation in ChildrenNicolaas G van der Maas, Erik G J von Asmuth, Dagmar Berghuis, et al.
Clinical Sarcoma Research|December 20, 2012
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic diseaseDagmar Berghuis, Marco W Schilham, Susy J Santos, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2012
Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsEmilie P Buddingh, S Eriaty N Ruslan, Dagmar Berghuis, et al.
International Journal of Molecular Sciences|November 14, 2023
Persistent Hypogammaglobulinemia after Receiving Rituximab Post-HSCT Is Not Caused by an Intrinsic B Cell DefectLisa M Ott de Bruin, Ingrid Pico-Knijnenburg, Monique M van Ostaijen-Ten Dam, et al.
Pageof 3